<DOC>
	<DOCNO>NCT01339247</DOCNO>
	<brief_summary>The study prospective , open , randomize , crossover steady state volunteer receive multiple dos test drug reference drug ( two period drug administration standardize meal ) .</brief_summary>
	<brief_title>Paxil CR Bioequivalence Study Brazil - Fed Administration</brief_title>
	<detailed_description>Title : Relative bioavailability study formulation : Paroxetine Hydrochloride 25 mg tablet control release ( Paxil CR ) manufacture GlaxoSmithKline Inc. - Mississauga - Canada ( test formulation ) Paroxetine Hydrochloride 25 mg tablet control release ( Paxil CR ) manufacture SmithKline Beecham ( Cork ) Limited - Cidra - Puerto Rico ( reference formulation ) , feed administration healthy volunteer gender . The study prospective , open , randomize , crossover steady state volunteer receive multiple dos drug test reference ( two period drug administration ) . The population compose 60 healthy volunteer , adult gender , age 18 40 year , body mass index ( BMI ) 18.5 27 . Volunteers weight 50 kg . 50 % volunteer recruit female 50 % male . There restriction regard ethnic group . The relative bioavailability formulation oral administration steady state evaluate base statistical comparison relevant pharmacokinetic parameter obtain data drug concentration blood . The concentration Paroxetine hydrochloride ( controlled release ) measure appropriate analytical method valid drug administration.The Pharmacokinetic sample collect steady state period standardize meal . The safety assessment include evaluation clinical monitoring , vital sign monitoring , ECG , laboratory test . Adverse event monitor throughout study .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Halofantrine</mesh_term>
	<criteria>EXCLUSION CRITERIA : hypersensitivity study drug compound chemically relate ; history serious adverse event ; concurrent recent use antidepressives , schizophrenia , anticonvulsant ; History liver , heart , gastrointestinal renal illness ; ECG finding recommend accord investigator judgement ; The volunteer ingest 5 cup coffee tea day . INCLUSION CRITERIA : Man woman ( since pregnant breastfeeding ) ; age 18 40 year ; nonsmoker addict ; mass index 18,5 27 ; good health condition without significant illness , judgement legally qualify professional ; sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Paroxetine reference/test</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>Fed condition</keyword>
</DOC>